<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0000107476</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>
      <contact>
        <contactName>Regina White</contactName>
        <contactPhoneNumber>801-532-1313</contactPhoneNumber>
        <contactEmailAddress>rwhite@wdco.com</contactEmailAddress>
      </contact>
      <flags>
        <overrideInternetFlag>false</overrideInternetFlag>
      </flags>
      <notifications>
        <notificationEmailAddress>rwhite@wdco.com</notificationEmailAddress>
      </notifications>
    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001514946</issuerCik>
      <issuerName>AXIM BIOTECHNOLOGIES, INC.</issuerName>
      <secFileNumber>000-54296</secFileNumber>
      <issuerAddress>
        <com:street1>6191 CORNERSTONE COURT, E</com:street1>
        <com:street2>SUITE 114</com:street2>
        <com:city>SAN DIEGO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92121</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(212) 751-0001</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>WILSON-DAVIS &amp; CO., INC.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Wilson Davis</name>
        <address>
          <com:street1>236 So. Main Street</com:street1>
          <com:city>Salt Lake City</com:city>
          <com:stateOrCountry>UT</com:stateOrCountry>
          <com:zipCode>84101</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>845012</noOfUnitsSold>
      <aggregateMarketValue>76051.00</aggregateMarketValue>
      <noOfUnitsOutstanding>164915277</noOfUnitsOutstanding>
      <approxSaleDate>09/15/2022</approxSaleDate>
      <securitiesExchangeName>N/A</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>08/23/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Debt Conversion</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Acquired from Issurer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>845012</amountOfSecuritiesAcquired>
      <paymentDate>02/10/2022</paymentDate>
      <natureOfPayment>Debt Conversion</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>1. The 845,012 shares were acquired via the conversion of a $25,000 note plus interest thereon.  The convertible note was acquired on February 10, 2022, with full cash payment of $25,000.</remarks>
    <noticeSignature>
      <noticeDate>10/06/2022</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>09/21/2022</planAdoptionDate>
      </planAdoptionDates>
      <signature>Blake N Schroeder</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
